Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Multi-center and Randomized Controlled Clinical Trial to Assess the Safety and Effectiveness of Tianyi Revascularization Device of in the Revascularization of Large Vessel Occlusion in Acute Ischemic Stroke

NCT05496361 is registered in ClinicalTrials.gov with Suzhou Zenith Vascular Scitech Co., Ltd. as lead sponsor.

NCT NCT05496361
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05496361 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Multi-center and Randomized Controlled Clinical Trial to Assess the Safety and Effectiveness of Tianyi Revascularization Device of in the Revascularization of Large Vessel Occlusion in Acute Ischemic Stroke
Lead sponsor
Suzhou Zenith Vascular Scitech Co., Ltd.
Phase
Not applicable
Overall status
Completed
Start date
January 24, 2021
Completion date
July 20, 2022
Enrollment
238 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute ischemic stroke, ais, large vessel occlusion, thrombectomy